title: [Choice of therapy based on clinical setting].
abstract: The choice of therapy in psoriasis is a complex multidimensional process based on both patient-related and disease-related factors. Standardisation of inclusion criteria for clinical trials leads to the exclusion of large numbers of patients with special forms of psoriasis or presenting comorbidities that must nevertheless be dealt with in real-life situations. The main patient-related factors affecting choice of therapy are age, pregnancy for women and the desire to father children for men, renal and hepatic failure, the risk of infection and neoplasia, metabolic and both cardiovascular and psychiatric comorbidities, as well as compliance and lifestyle. Disease-related factors affecting choice of therapy include unstable lesions, acral sites (palms, soles, nails, face and scalp), erythrodermic psoriasis, pustular psoriasis, guttate psoriasis and associated psoriatic rheumatism. The therapeutic recommendations set out in this study are based upon a critical analysis of the literature and upon the actual therapeutic practice of the experts.
authors.affiliation: Hôpital Larrey, université Paul-Sabatier et dermatologie, 24, chemin de Pouvourville, 31059 Toulouse, France. paul.c@chu-toulouse.fr
authors.forename: C
authors.initials: C
authors.lastname: Paul
authors.forename: H
authors.initials: H
authors.lastname: Bachelez
mesh_terms: D000367:Age Factors; D015897:Comorbidity; D000075202:Contraindications; D016572:Cyclosporine; D003657:Decision Making; D003879:Dermatologic Agents; D005260:Female; D048550:Hepatic Insufficiency / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D055985:Latent Tuberculosis / Q000150:complications; D001523:Mental Disorders / Q000150:complications; D008727:Methotrexate; D011247:Pregnancy; D011565:Psoriasis / Q000628:therapy*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D003879:Dermatologic Agents; D016572:Cyclosporine; D008727:Methotrexate